Gene · 2195
Papers4,590
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 4,590
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sensitivities and Dependencies of BRAF Mutant Colorectal Cancer Cell Lines with or without PIK3CA Mutations for Discovery of Vulnerabilities with Therapeutic Potential. | Medicina (Kaunas) | 2022 | 36295658 | PubTator, text mining | PubMed |
| Integrating Genetic Alterations and the Hippo Pathway in Head and Neck Squamous Cell Carcinoma for Future Precision Medicine. | J Pers Med | 2022 | 36294681 | PubTator, text mining | PubMed |
| Mutation Analysis of Thin Basement Membrane Nephropathy. | Genes (Basel) | 2022 | 36292665 | PubTator, text mining | PubMed |
| Multidisciplinary Progress in Obesity Research. | Genes (Basel) | 2022 | 36292657 | PubTator, text mining | PubMed |
| The Role of Genomics and Proteomics in Lung Cancer Early Detection and Treatment. | Cancers (Basel) | 2022 | 36291929 | PubTator, text mining | PubMed |
| Molecular Characteristics of Radon Associated Lung Cancer Highlights MET Alterations. | Cancers (Basel) | 2022 | 36291897 | PubTator, text mining | PubMed |
| Clinical Practice of Targeted Capture Sequencing to Identify Actionable Alterations in Cholangiocarcinoma. | Cancers (Basel) | 2022 | 36291846 | PubTator, text mining | PubMed |
| Exploiting the Molecular Basis of Oesophageal Cancer for Targeted Therapies and Biomarkers for Drug Response: Guiding Clinical Decision-Making. | Biomedicines | 2022 | 36289620 | PubTator, text mining | PubMed |
| Decitabine-induced DNA methylation-mediated transcriptomic reprogramming in human breast cancer cell lines; the impact of DCK overexpression. | Front Pharmacol | 2022 | 36278182 | PubTator, text mining | PubMed |
| Lipid metabolism in type 1 diabetes mellitus: Pathogenetic and therapeutic implications. | Front Immunol | 2022 | 36275658 | PubTator, text mining | PubMed |
| Clinical associations and genetic interactions of oncogenic BRAF alleles. | PeerJ | 2022 | 36275468 | PubTator, text mining | PubMed |
| From COPD to Lung Cancer: Mechanisms Linking, Diagnosis, Treatment, and Prognosis. | Int J Chron Obstruct Pulmon Dis | 2022 | 36274992 | PubTator, text mining | PubMed |
| Characterization of somatic structural variations in 528 Chinese individuals with Esophageal squamous cell carcinoma. | Nat Commun | 2022 | 36272974 | PubTator, text mining | PubMed |
| Improving feature extraction from histopathological images through a fine-tuning ImageNet model. | J Pathol Inform | 2022 | 36268072 | PubTator, text mining | PubMed |
| A review on the role of cyclin dependent kinases in cancers. | Cancer Cell Int | 2022 | 36266723 | PubTator, text mining | PubMed |
| Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract. | Cancer Commun (Lond) | 2022 | 36264285 | PubTator, text mining | PubMed |
| Clonal relationship and alcohol consumption-associated mutational signature in synchronous hypopharyngeal tumours and oesophageal squamous cell carcinoma. | Br J Cancer | 2022 | 36261585 | PubTator, text mining | PubMed |
| IPSS-M has greater survival predictive accuracy compared with IPSS-R in persons ≥ 60 years with myelodysplastic syndromes. | Exp Hematol Oncol | 2022 | 36253799 | PubTator, text mining | PubMed |
| A new machine learning method for cancer mutation analysis. | PLoS Comput Biol | 2022 | 36251702 | PubTator, text mining | PubMed |
| TP53 mutation-associated immune infiltration and a novel risk score model in HNSCC. | Biochem Biophys Rep | 2022 | 36248764 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2195/papers?page=55